• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌的分期。澳大利亚临床病理分期(ACPS)系统与杜克系统的比较。

Staging of colorectal cancer. The Australian clinico-pathological staging (ACPS) system compared with Dukes' system.

作者信息

Davis N C, Evans E B, Cohen J R, Theile D E

出版信息

Dis Colon Rectum. 1984 Nov;27(11):707-13. doi: 10.1007/BF02554593.

DOI:10.1007/BF02554593
PMID:6499604
Abstract

A new system, the Australian Clinico-pathological Staging (ACPS) System, has recently been proposed for the recording and reporting of colorectal carcinoma. This system requires the accurate use of precise definitions, cooperation between surgeons and pathologist, and a complete pathology report. It utilizes all information available--clinical, radiologic, operative, pathologic--before a stage is allotted. This contrasts with Dukes' system, which is based solely on the pathologic examination of the resected carcinoma. It allows classifications of all cases of colorectal cancer seen, whether treated by resection, palliative surgery, local excision or not at all. The stage at presentation and the five-year survival of 490 patients with colorectal cancer are compared using the ACPS and Dukes' systems. Eighty-four cases were not classifiable under Dukes' system, and there was a significant difference in survival in one of the comparable groups of patients.

摘要

最近有人提出了一种新的系统——澳大利亚临床病理分期(ACPS)系统,用于结直肠癌的记录和报告。该系统要求准确使用精确的定义,外科医生和病理学家之间密切合作,并出具完整的病理报告。在分配分期之前,它会利用所有可用信息——临床、放射学、手术、病理等信息。这与仅基于切除癌病理检查的Dukes系统形成对比。它能够对所有结直肠癌病例进行分类,无论这些病例是接受了切除术、姑息性手术、局部切除术还是根本未接受治疗。运用ACPS系统和Dukes系统对490例结直肠癌患者的就诊时分期和五年生存率进行了比较。有84例病例无法按照Dukes系统进行分类,并且在一组具有可比性的患者中,生存率存在显著差异。

相似文献

1
Staging of colorectal cancer. The Australian clinico-pathological staging (ACPS) system compared with Dukes' system.结直肠癌的分期。澳大利亚临床病理分期(ACPS)系统与杜克系统的比较。
Dis Colon Rectum. 1984 Nov;27(11):707-13. doi: 10.1007/BF02554593.
2
Terminology and classification of colorectal adenocarcinoma: the Australian clinico-pathological staging system.结直肠癌的术语和分类:澳大利亚临床病理分期系统
Aust N Z J Surg. 1983 Jun;53(3):211-21. doi: 10.1111/j.1445-2197.1983.tb02430.x.
3
Colorectal cancer: the relationship of staging to survival. A cancer registry study of 800 cases in St. Gallen-Appenzell.结直肠癌:分期与生存率的关系。圣加仑-阿彭策尔800例癌症登记研究。
Soz Praventivmed. 1986;31(2):85-8. doi: 10.1007/BF02091591.
4
Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.结直肠癌新临床病理分期系统的验证
Ann Surg. 1991 Jul;214(1):11-8. doi: 10.1097/00000658-199107000-00003.
5
Contributions of pathologic margins and Dukes' stage to local recurrence in colorectal carcinoma.病理切缘和杜克分期对结直肠癌局部复发的影响
Am J Surg. 1985 Mar;149(3):323-6. doi: 10.1016/s0002-9610(85)80099-4.
6
Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study.大肠癌患者的生存率。来自墨尔本结直肠癌研究的一项基于人群的调查。
Dis Colon Rectum. 1990 Nov;33(11):938-46. doi: 10.1007/BF02139103.
7
The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.外科医生和病理学家对结直肠癌淋巴结清扫的影响及其对Dukes B期患者生存率的影响。
Colorectal Dis. 2008 Feb;10(2):157-64. doi: 10.1111/j.1463-1318.2007.01225.x. Epub 2007 Mar 7.
8
Delay of treatment is associated with advanced stage of rectal cancer but not of colon cancer.治疗延迟与直肠癌的晚期阶段相关,但与结肠癌无关。
Cancer Detect Prev. 2006;30(4):341-6. doi: 10.1016/j.cdp.2006.07.001. Epub 2006 Sep 11.
9
The reporting of colorectal cancer: the Australian Clinico-pathological Staging (ACPS) System.
Med J Aust. 1983 Mar 19;1(6):282.
10
Carcinomas of the colon and rectum. A comparison of staging classifications.结肠和直肠癌。分期分类比较。
Am Surg. 1986 Aug;52(8):428-33.

引用本文的文献

1
Geographic and Socioeconomic Disparities in Emergency Presentations Among Colorectal Cancer Patients in Victoria, Australia.澳大利亚维多利亚州结直肠癌患者急诊就诊的地理和社会经济差异
Cancer Med. 2025 May;14(9):e70909. doi: 10.1002/cam4.70909.
2
Tailored recruitment interventions to improve bowel cancer screening in Arabic and Mandarin speaking groups: Modelled cost-effectiveness.针对阿拉伯语和普通话群体的结肠癌筛查的定制招募干预措施:建模成本效益。
PLoS One. 2024 Nov 14;19(11):e0313058. doi: 10.1371/journal.pone.0313058. eCollection 2024.
3
Special cancer microenvironment in human colonic cancer: Concept of cancer microenvironment formed by peritoneal invasion (CMPI) and implication of subperitoneal fibroblast in cancer progression.
人类结肠癌中的特殊癌症微环境:由腹膜侵袭形成的癌症微环境概念(CMPI)及腹膜下成纤维细胞在癌症进展中的意义。
Pathol Int. 2016 Mar;66(3):123-131. doi: 10.1111/pin.12389. Epub 2016 Jan 27.
4
Concomitant tumor expression of EGFR and TATI/SPINK1 associates with better prognosis in colorectal cancer.表皮生长因子受体(EGFR)与组织激肽释放酶抑制剂1(TATI/SPINK1)在肿瘤中的共同表达与结直肠癌较好的预后相关。
PLoS One. 2013 Oct 25;8(10):e76906. doi: 10.1371/journal.pone.0076906. eCollection 2013.
5
Lack of MMP-9 expression is a marker for poor prognosis in Dukes' B colorectal cancer.基质金属蛋白酶-9表达缺失是 Dukes' B 期结直肠癌预后不良的一个标志物。
BMC Clin Pathol. 2012 Dec 7;12:24. doi: 10.1186/1472-6890-12-24.
6
MMP-7 as a prognostic marker in colorectal cancer.基质金属蛋白酶-7作为结直肠癌的预后标志物
Tumour Biol. 2011 Apr;32(2):259-64. doi: 10.1007/s13277-010-0080-2. Epub 2010 Aug 28.
7
Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC.腹部结肠切除术后遗传性非息肉病性结直肠癌患者的直肠癌风险。遗传性非息肉病性结直肠癌国际协作组
Ann Surg. 1997 Feb;225(2):202-7. doi: 10.1097/00000658-199702000-00008.
8
The prognostic value of the modifications of the Dukes' C class of colorectal cancer. An analysis of the NSABP clinical trials.结直肠癌Dukes' C期改良的预后价值。NSABP临床试验分析。
Ann Surg. 1986 Feb;203(2):115-22. doi: 10.1097/00000658-198602000-00001.
9
Synthesis of type I collagen in healing wounds in humans.人类愈合伤口中I型胶原蛋白的合成。
Ann Surg. 1991 Jan;213(1):75-80. doi: 10.1097/00000658-199101000-00013.